2BB score and signals
Caribou Biosciences, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 62 | High |
| Momentum | 64 | Improving |
| Financial strength | 11 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Berkeley, California, United States |
| Founded | Jan 1, 2011 |
| Employees | 97 |
| 52-week range | $1.38 – $3.53 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.3096 | — | $2.24M |
| 2026-08-13 | — | -0.3232 | — | $2.32M |
| 2026-05-07 | -0.26 | -0.3242 | $2.40M | $2.29M |
| 2026-03-05 | -0.28 | -0.3162 | $3.94M | $2.57M |
Related companies
2BBBullish & Bearish